Cargando…
Ocular Surface Alterations and Topical Antiglaucomatous Therapy: A Review
Ocular Surface Disease (OSD) is prevalent among medically treated patients with glaucoma. This is basically related to three key-points: OSD and glaucoma are both prevalent in elderly and are common comorbidities in the same patient; the role of the active ingredient of the medical antiglaucomatous...
Autores principales: | Actis, Alessandro G, Rolle, Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192829/ https://www.ncbi.nlm.nih.gov/pubmed/25317218 http://dx.doi.org/10.2174/1874364101408010067 |
Ejemplares similares
-
Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops
por: Lajmi, Houda, et al.
Publicado: (2021) -
Regulation of Retinal Proteome by Topical Antiglaucomatous Eye Drops in an Inherited Glaucoma Rat Model
por: Schallenberg, Maurice, et al.
Publicado: (2012) -
Patient persistence with first-line antiglaucomatous monotherapy
por: Arias, Alfonso, et al.
Publicado: (2010) -
Particulate Systems
in the Enhancement of the Antiglaucomatous
Drug Pharmacodynamics: A Meta-Analysis Study
por: Hathout, Rania M.
Publicado: (2019) -
Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome
por: Chang, Chih-Chiun J., et al.
Publicado: (2022)